IBDEI0FI ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7125,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7125,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,7125,1,5,0)
 ;;=5^HX Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,7125,2)
 ;;=^295234
 ;;^UTILITY(U,$J,358.3,7126,0)
 ;;=V10.71^^31^428^16
 ;;^UTILITY(U,$J,358.3,7126,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7126,1,4,0)
 ;;=4^V10.71
 ;;^UTILITY(U,$J,358.3,7126,1,5,0)
 ;;=5^HX Lymphosarcoma
 ;;^UTILITY(U,$J,358.3,7126,2)
 ;;=^295236
 ;;^UTILITY(U,$J,358.3,7127,0)
 ;;=V10.72^^31^428^10
 ;;^UTILITY(U,$J,358.3,7127,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7127,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,7127,1,5,0)
 ;;=5^HX Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,7127,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,7128,0)
 ;;=V10.81^^31^428^2
 ;;^UTILITY(U,$J,358.3,7128,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7128,1,4,0)
 ;;=4^V10.81
 ;;^UTILITY(U,$J,358.3,7128,1,5,0)
 ;;=5^HX Bone Malignancy
 ;;^UTILITY(U,$J,358.3,7128,2)
 ;;=^295239
 ;;^UTILITY(U,$J,358.3,7129,0)
 ;;=V10.82^^31^428^17
 ;;^UTILITY(U,$J,358.3,7129,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7129,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,7129,1,5,0)
 ;;=5^HX Malig Melanom Skin
 ;;^UTILITY(U,$J,358.3,7129,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,7130,0)
 ;;=V10.83^^31^428^24
 ;;^UTILITY(U,$J,358.3,7130,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7130,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,7130,1,5,0)
 ;;=5^HX Other Skin Malig
 ;;^UTILITY(U,$J,358.3,7130,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,7131,0)
 ;;=V10.85^^31^428^3
 ;;^UTILITY(U,$J,358.3,7131,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7131,1,4,0)
 ;;=4^V10.85
 ;;^UTILITY(U,$J,358.3,7131,1,5,0)
 ;;=5^HX Brain Malig
 ;;^UTILITY(U,$J,358.3,7131,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,7132,0)
 ;;=V10.87^^31^428^31
 ;;^UTILITY(U,$J,358.3,7132,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7132,1,4,0)
 ;;=4^V10.87
 ;;^UTILITY(U,$J,358.3,7132,1,5,0)
 ;;=5^HX Thyroid Malig
 ;;^UTILITY(U,$J,358.3,7132,2)
 ;;=^295245
 ;;^UTILITY(U,$J,358.3,7133,0)
 ;;=V10.88^^31^428^7
 ;;^UTILITY(U,$J,358.3,7133,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7133,1,4,0)
 ;;=4^V10.88
 ;;^UTILITY(U,$J,358.3,7133,1,5,0)
 ;;=5^HX Endocrine Malig
 ;;^UTILITY(U,$J,358.3,7133,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,7134,0)
 ;;=V10.86^^31^428^21
 ;;^UTILITY(U,$J,358.3,7134,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7134,1,4,0)
 ;;=4^V10.86
 ;;^UTILITY(U,$J,358.3,7134,1,5,0)
 ;;=5^HX Nervous System Malig
 ;;^UTILITY(U,$J,358.3,7134,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,7135,0)
 ;;=V12.42^^31^429^1
 ;;^UTILITY(U,$J,358.3,7135,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7135,1,4,0)
 ;;=4^V12.42
 ;;^UTILITY(U,$J,358.3,7135,1,5,0)
 ;;=5^Persl HX Infec CNS
 ;;^UTILITY(U,$J,358.3,7135,2)
 ;;=^332853
 ;;^UTILITY(U,$J,358.3,7136,0)
 ;;=V12.60^^31^429^5
 ;;^UTILITY(U,$J,358.3,7136,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7136,1,4,0)
 ;;=4^V12.60
 ;;^UTILITY(U,$J,358.3,7136,1,5,0)
 ;;=5^Persl HX Resp Sys Dis NOS
 ;;^UTILITY(U,$J,358.3,7136,2)
 ;;=^332854
 ;;^UTILITY(U,$J,358.3,7137,0)
 ;;=V12.61^^31^429^3
 ;;^UTILITY(U,$J,358.3,7137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7137,1,4,0)
 ;;=4^V12.61
 ;;^UTILITY(U,$J,358.3,7137,1,5,0)
 ;;=5^Persl HX Recur Pneumonia
 ;;^UTILITY(U,$J,358.3,7137,2)
 ;;=^332855
 ;;^UTILITY(U,$J,358.3,7138,0)
 ;;=V12.69^^31^429^4
 ;;^UTILITY(U,$J,358.3,7138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7138,1,4,0)
 ;;=4^V12.69
 ;;^UTILITY(U,$J,358.3,7138,1,5,0)
 ;;=5^Persl HX Resp Sys Dis NEC
 ;;^UTILITY(U,$J,358.3,7138,2)
 ;;=^332856
 ;;^UTILITY(U,$J,358.3,7139,0)
 ;;=V13.02^^31^429^6
 ;;
 ;;$END ROU IBDEI0FI
